Cytogenix (fka CYGX)

[neo43]

gdepc, I should've said "If it's true . . .

that CYGX needs another backbone to make its products work, MS would be a fool to announce it in a forum like the interview with Wall Street Reporter."

I didn't bring up the issue in the first place -- I believe it was happycamper who did that -- and I don't know whether it's true. However, I think the quote found by arnold gives it some credence. ("Negotiations are being conducted to obtain the rights to use a further identified alternative backbone in combination with the sequences we have discovered and found successful.")

I will admit, though, that the significance of this sentence is very uncertain, and, as is typical of their pitiful IR, the company hasn't bothered to clarify it.